Mandate

Advokatfirman Vinge has advised the sellers in connection with Tencent Holdings Ltd acquisition of Sharkmob AB

May 23, 2019 M&A

Advokatfirman Vinge has advised the sellers of the Swedish game developer Sharkmob in connection with Tencent Holdings acquisition of the company for an undisclosed sum.

​Sharkmob was founded two years ago by a tight-knit group of industry veterans, and they have since grown steadily at their iconic Malmö office. The studio will continue working with its unannounced online game as well as several new projects together with Tencent Holdings.

Tencent Holdings is a Hong Kong based tech company whose internet solutions are used by over one billion netizens (citizen of the net). Their two principal business operations are social platforms and digital content and they are widely recognized as the biggest gaming company in the world.

The full press release can be found here www.sharkmob.com/press-release.

“We engaged Advokatfirman Vinge and Christian Riddarbo in this transaction due to the firm´s extensive expertise in complex cross-border transactions and in particular working with and for Chinese companies which we understand often require experience of Chinese business structures, decision-making processes and specific legal considerations.”, said Kristofer Westergren, former shareholder and resigning Chairman of Sharkmob.

Vinge’s team primarily consisted of Christian Riddarbo (M&A), Fredrik Sonander (M&A), Victor Ericsson (Tax), Jenny Sandlund (M&A), Hampus Wahlberg (General Corporate), Adam Loewenstein (General Corporate) and Camilla Andersson (VDR).

Related

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.
May 30, 2024

Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024